Tumour-shrinking decoction for symptomatic
uterine fibroids: a double-blind, randomised,
two-dose trial (abridged secondary publication)
W Meng1, L Lao1, ZJ Zhang1, WL Lin2, YB Zhang1, WF Yeung3, YMB Yu3, HYE Ng1, JP Chen1, J Su1, JH Rong1, PYF Lam1, E Lee1
1 LKS Faculty of Medicine, The University of Hong Kong
2 Hong Kong Institute of Integrative Medicine, Faculty of Medicine, The Chinese University of Hong Kong
3 School of Nursing, The Hong Kong Polytechnic University
Both low-dose and high-dose tumour-shrinking
decoction could improve the uterine fibroid–related
symptoms and reduce the fibroid size after 16 weeks
of treatment.